Literature DB >> 9850876

The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients.

D G Harwood1, R L Ownby, W W Barker, R Duara.   

Abstract

OBJECTIVE: The aims of this study were to (a) determine the factor structure of the Behavioral Pathology in Alzheimer's Disease Scale (BEHAVE-AD), and (b) examine the associations of the observed factors to the level of cognitive impairment.
DESIGN: Cross-sectional study of geriatric patients evaluated at an outpatient memory disorders clinic. SAMPLE: One hundred and fifty-one consecutive patients diagnosed with Alzheimer's disease (AD) according to NINCDS-ADRDA diagnostic criteria.
RESULTS: Principal factors analysis with Varimax rotation resulted in a five-factor solution that accounted for 40.0% of the common variance. The factors included agitation/anxiety (agitation, anxiety of upcoming events; other anxiety), psychosis (delusions of theft, suspiciousness/paranoia; visual hallucinations), aggression (verbal aggressiveness; physical threats/violence; fear of being left alone; other delusions), depression (tearfulness; depressed mood) and activity disturbance (wandering; delusion one's house is not one's home). Several factors were associated with level of cognitive impairment as assessed by the Mini-Mental State Examination (MMSE).
CONCLUSION: The results of this study suggest that the BEHAVE-AD measures a wide range of behavioral pathology that can be empirically represented by five independent symptom clusters among outpatient AD patients.

Entities:  

Mesh:

Year:  1998        PMID: 9850876     DOI: 10.1002/(sici)1099-1166(1998110)13:11<793::aid-gps875>3.0.co;2-q

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

Review 1.  Treatment approaches to symptoms associated with frontotemporal degeneration.

Authors:  Tiffany W Chow
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

2.  [Maintenance of health and relief for caregivers of elderly with dementia by using "initial case management": experiences from the Lighthouse Project on Dementia, Ulm, ULTDEM-study].

Authors:  A Lukas; R Kilian; B Hay; R Muche; C A F von Arnim; M Otto; M Riepe; M Jamour; M D Denkinger; T Nikolaus
Journal:  Z Gerontol Geriatr       Date:  2012-06       Impact factor: 1.281

3.  A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.

Authors:  Zahinoor Ismail; Chetachi A Emeremni; Patricia R Houck; Sati Mazumdar; Jules Rosen; Tarek K Rajji; Bruce G Pollock; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-02       Impact factor: 4.105

Review 4.  The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?

Authors:  Daniel L Murman; Christopher C Colenda
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 5.  Anxiety in dementia: a critical review.

Authors:  Paul J Seignourel; Mark E Kunik; Lynn Snow; Nancy Wilson; Melinda Stanley
Journal:  Clin Psychol Rev       Date:  2008-03-07

6.  Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders.

Authors:  Renaud David; Emmanuel Mulin; Patrick Mallea; Philippe H Robert
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-26

7.  Behavioral and psychological symptoms of dementia.

Authors:  J Cerejeira; L Lagarto; E B Mukaetova-Ladinska
Journal:  Front Neurol       Date:  2012-05-07       Impact factor: 4.003

Review 8.  Appetite, Metabolism and Hormonal Regulation in Normal Ageing and Dementia.

Authors:  Artemissia-Phoebe Nifli
Journal:  Diseases       Date:  2018-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.